What is Emergent Biosolutions's total equity?

Emergent Biosolutions (EBS) reported total equity of $523.1M in Q1 2026.

How has Emergent Biosolutions's total equity changed year-over-year?

Emergent Biosolutions's total equity decreased by 5.4% year-over-year, from $552.7M to $523.1M.

What is the long-term trend for Emergent Biosolutions's total equity?

Over 5 years (2020 to 2025), Emergent Biosolutions's total equity has grown at a -18.5% compound annual growth rate (CAGR), from $1.45B to $522.6M.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Emergent Biosolutions EBS Total Equity

Total Equity at other companies

Thermo Fisher ScientificTMO

$51.93B+5.2%

Regeneron PharmaceuticalsREGN

$31.42B+6.9%

Amneal Pharmaceuticals, Inc.AMRX

-$45.41M+65.5%

CorMedixCRMD

$437.05M+280%

Collegium Pharmaceutical, Inc.COLL

$312.42M+33.3%

Opko HealthOPK

$1.2B-8.2%

Other financials

Income statement

See full

Revenue$156.1M-29.7%

Gross profit$84.1M-37.1%

Operating income$10.5M-79.0%

Net income$6.8M-90.0%

EPS (diluted)$0.07-94.1%

Balance sheet

See full

Cash & equivalents$161.5M+5.7%

Total debt$584.6M-13.1%

Total assets$1.3B-7.4%

Cash flow

See full

Operating cash flow-$33.8M-202%

CapEx$2.4M-33.3%

Free cash flow-$36.2M-145%

Valuation

See full

Market cap$411.74M+22.0%

Enterprise value$834.84M-2.6%

P/E3.6×—

P/S0.6×+0.3×

Profitability

See full

Gross margin54.2%+19.0pp

Operating margin15%+10.3pp

Net margin9.6%+5.8pp

FCF margin20.8%—

Returns & leverage

See full

Return on equity13.9%+8.1pp

Debt / equity1.1×-0.1×

Current ratio4.3×-2.0×

Where this comes from

Reported directly by Emergent Biosolutions in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Emergent Biosolutions's total equity?: Emergent Biosolutions (EBS) reported total equity of $523.1M in Q1 2026.
How has Emergent Biosolutions's total equity changed year-over-year?: Emergent Biosolutions's total equity decreased by 5.4% year-over-year, from $552.7M to $523.1M.
What is the long-term trend for Emergent Biosolutions's total equity?: Over 5 years (2020 to 2025), Emergent Biosolutions's total equity has grown at a -18.5% compound annual growth rate (CAGR), from $1.45B to $522.6M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.